A Study to Evaluate the Safety and Potential Efficacy of LT3001 Drug Product in Subjects With AIS
Clinical trial NCT04091945 · COMPLETED
Trial details
- NCT number
- NCT04091945
- Sponsor
- Lumosa Therapeutics Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-27
- Primary completion
- 2021-02-22
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.